title: Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis.
abstract: Proteinacious intracellular aggregates in motor neurons are a key feature of both sporadic and familial amyotrophic lateral sclerosis (ALS). These inclusion bodies are often immunoreactive for Cu,Zn-superoxide dismutase (SOD1) and are implicated in the pathology of ALS. On the basis of this and a similar clinical presentation of symptoms in the familial (fALS) and sporadic forms of ALS, we sought to investigate the possibility that there exists a common disease-related aggregation pathway for fALS-associated mutant SODs and wild type SOD1. We have previously shown that oxidation of fALS-associated mutant SODs produces aggregates that have the same morphological, structural, and tinctorial features as those found in SOD1 inclusion bodies in ALS. Here, we show that oxidative damage of wild type SOD at physiological concentrations ( approximately 40 microm) results in destabilization and aggregation in vitro. Oxidation of either mutant or wild type SOD1 causes the enzyme to dissociate to monomers prior to aggregation. Only small changes in secondary and tertiary structure are associated with monomer formation. These results indicate a common aggregation prone monomeric intermediate for wild type and fALS-associated mutant SODs and provides a link between sporadic and familial ALS.
authors.affiliation: Departments of Medical Biophysics and Biochemistry, University of Toronto, Toronto, Ontario M5G 2M9, Canada.
authors.forename: Rishi
authors.initials: R
authors.lastname: Rakhit
authors.forename: John P
authors.initials: JP
authors.lastname: Crow
authors.forename: James R
authors.initials: JR
authors.lastname: Lepock
authors.forename: Leslie H
authors.initials: LH
authors.lastname: Kondejewski
authors.forename: Neil R
authors.initials: NR
authors.lastname: Cashman
authors.forename: Avijit
authors.initials: A
authors.lastname: Chakrabartty
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology*; D000817:Anilino Naphthalenesulfonates / Q000494:pharmacology; D002151:Calorimetry; D002853:Chromatography, Liquid; D002942:Circular Dichroism; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000201:enzymology; D005456:Fluorescent Dyes / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008027:Light; D013058:Mass Spectrometry; D008958:Models, Molecular; D009154:Mutation; D010100:Oxygen / Q000378:metabolism*; D011485:Protein Binding; D017510:Protein Folding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D012542:Scattering, Radiation; D013482:Superoxide Dismutase / Q000737:chemistry*; D013696:Temperature; D014364:Tryptophan / Q000494:pharmacology; D014461:Ultracentrifugation
chemical_list: D000817:Anilino Naphthalenesulfonates; D005456:Fluorescent Dyes; C027132:1-anilino-8-naphthalenesulfonate; D014364:Tryptophan; D013482:Superoxide Dismutase; D010100:Oxygen